Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race

Editor's pick
Xconomy
25 January 2012
New & experimental HIV treatments

Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir

Editor's pick
Gilead press release
24 January 2012
PrEP

Gilead not immune to concern over Truvada's wider HIV use

Editor's pick
Financial Times
24 January 2012
New & experimental hepatitis C treatment

Achillion's Hep C Pipeline Likely Can't Compete

Editor's pick
BioMed Reports
19 January 2012
HIV treatment for children & young people

U.S. Food and Drug Administration Approves New Formulations of Viread(R) for Use by Children Living With HIV

Editor's pick
CNBC
19 January 2012
Pharmaceutical industry

Pfizer tests a concept that could modernize drug studies

Editor's pick
NJ.com
17 January 2012
Pharmaceutical industry

Bristol-Myers Raised Offer 30% to Beat Competitor for Inhibitex

Editor's pick
Bloomberg Business Week
17 January 2012
Access to healthcare

Trends In Compulsory Licensing Of Pharmaceuticals Since Doha Declaration

Editor's pick
Kaiser Daily Global Health Policy Report
12 January 2012
New & experimental hepatitis C treatment

Idenix Reports Advancement of HCV Development Pipeline

Editor's pick
Idenix (press release)
11 January 2012
New & experimental hepatitis C treatment

Achillion Reports Clinical Data on Portfolio of HCV Protease Inhibitors

Editor's pick
Achillion (press release)
11 January 2012
Pharmaceutical industry

FDA says Merck's HIV drug gets generic threat

Editor's pick
Reuters
10 January 2012
Pharmaceutical industry

Merck Hepatitis C Drug May `Anchor' Future Worldwide Regimen

Editor's pick
Bloomberg
10 January 2012
The search for a cure

Sangamo BioSciences Announces Initiation of Two New Phase 2 HIV Clinical Trials

Editor's pick
PR Newswire
9 January 2012
Pharmaceutical industry

Bristol Buys Inhibitex for $2.5 Billion to Compete in Hepatitis

Editor's pick
Bloomberg BusinessWeek
9 January 2012
Finance & funding

Study finds statin costs 400 percent higher in US compared to UK

Editor's pick
Eurekalert Medicine & Health
5 January 2012
Access to healthcare

US: Companies Lower HIV Drug Prices for ADAP, but Many Patients Still Waiting

Editor's pick
HIVandHepatitis.com
3 January 2012
Access to healthcare

Johnson & Johnson Says "No" to Joining the Medicines Patent Pool

Editor's pick
Medicines Patent Pool
22 December 2011
New & experimental HIV treatments

Gilead Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection

Editor's pick
Gilead press release
21 December 2011
Pharmaceutical industry

Gilead's New HIV Drug Pipeline: What You Need To Know For 2012

Editor's pick
Seeking Alpha
20 December 2011
Starting treatment

New Roche Screening Test for Abacavir Hypersensitivity Available in Europe

Editor's pick
AEGiS
19 December 2011
PrEP

US to rule on preventive use of HIV drug

Editor's pick
Financial Times
16 December 2011
PrEP

Gilead Seeks FDA Approval For Truvada In Reducing HIV Risk In Uninfected Adults

Editor's pick
RTT News
15 December 2011
New & experimental HIV treatments

Novel HIV-Associated Diarrhea Drug Crofelemer Goes to FDA for Approval Review

Editor's pick
AIDSMeds.com
15 December 2011
New & experimental HIV treatments

Aethlon Medical Announces HIV-AIDS Research Discovery

Editor's pick
PR Newswire (press release)
15 December 2011